Financial Analysis: Wound Management Technologies (WNDM) and Intuitive Surgical (ISRG)

Financial Analysis: Wound Management Technologies (WNDM) and Intuitive Surgical (ISRG)

Intuitive Surgical (NASDAQ:ISRG) and Wound Management Technologies (OTCMKTS:WNDM) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, dividends, risk and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Intuitive Surgical and Wound Management Technologies, as reported by MarketBeat.

Intuitive Surgical currently has a consensus target price of $558.39, indicating a potential upside of 7.63%. Given Intuitive Surgical’s higher probable upside, analysts clearly believe Intuitive Surgical is more favorable than Wound Management Technologies.

Valuation & Earnings

This table compares Intuitive Surgical and Wound Management Technologies’ top-line revenue, earnings per share (EPS) and valuation.

Intuitive Surgical has higher revenue and earnings than Wound Management Technologies.

Profitability

This table compares Intuitive Surgical and Wound Management Technologies’ net margins, return on equity and return on assets.

Institutional & Insider Ownership

84.3% of Intuitive Surgical shares are held by institutional investors. 2.2% of Intuitive Surgical shares are held by insiders. Comparatively, 9.6% of Wound Management Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Volatility & Risk

Intuitive Surgical has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Wound Management Technologies has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Summary

Intuitive Surgical beats Wound Management Technologies on 9 of the 11 factors compared between the two stocks.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. Its da Vinci surgical system include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments that include forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci Single-Site instruments and accessories that allow surgical systems to work through a single incision; and EndoWrist One vessel sealers that are wristed single-use instruments intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist stapler, a wristed stapling instrument intended for resection, transection, and/or creation of anastomoses, as well as sells various accessories, including replacement 3-D stereo endoscopes, camera heads, light guides, and other items that facilitate use of the da Vinci system, as well as sterile drapes for ensuring a sterile field during surgery. Intuitive Surgical, Inc. markets its products directly and through distributors in the United States, Europe, Asia, and internationally. The company was founded in 1995 and is headquartered in Sunnyvale, California.

Wound Management Technologies Company Profile

WNDM Medical Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. The company offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as Wound Management Technologies, Inc. and changed its name to WNDM Medical Inc. in April 2017. WNDM Medical Inc. was founded in 1982 and is based in Fort Worth, Texas.

Related posts

Leave a Comment